Search

everythinglearnresearchcommunity

for

Search:↓

CAR-T cell therapy shows promise for treating autoimmune disorders but faces challenges like complex manufacturing and limited tissue penetration.

Systemic corticosteroids help manage vitiligo by slowing progression and aiding repigmentation.

Thymic transplantation normalized some T-cells but not others, maintaining immune function.

Psoriasis involves an imbalance between certain immune cells, and targeting these could help restore skin health.

Combining MMP-9 and JAK inhibitors can effectively prevent skin depigmentation in vitiligo.

γδT cells can protect hair follicles from alopecia areata and promote hair regrowth.

Topical tacrolimus is safe and effective for skin conditions, but oral tacrolimus has serious side effects.

Upadacitinib improved multiple immune-related conditions in one patient.

Dexamethasone-primed stem cell media shows promise in treating lupus by reducing symptoms and inflammation.

Aldesleukin can treat certain cancers and increase HIV patient CD4+ counts but often causes severe side effects.

Regulatory T cells help heal skin wounds by reducing inflammation and promoting tissue repair.

Researchers found that certain miRNAs, which affect immune system regulation, are differently expressed in mice with a hair loss condition compared to healthy mice.

Diphencyprone is effective for treating patchy hair loss in alopecia areata, but tacrolimus is not.

Biologic therapies can cause various adverse events, but allergy/immunology clinicians can manage them.

Astilbin can potentially calm overactive immune responses, like in Type 1 Diabetes, by suppressing certain cell activities and reducing inflammation.

Topical calcineurin inhibitors, especially 0.1% tacrolimus ointment, are effective and well-tolerated for treating cutaneous lupus erythematosus but require more research for standard treatment guidelines.

The study created special nanoparticles that effectively deliver an anti-inflammatory drug to treat skin inflammation in psoriasis.

Alopecia areata involves unique activation of certain immune cells.

Blocking certain immune signals can reduce skin damage from radiation therapy.

The nail matrix has a reduced immune response, protecting it from autoimmunity.

Blocking IL-12 can help treat alopecia areata by preventing hair follicle immune issues.

Budesonide alone is less effective than standard treatment for autoimmune hepatitis.

Dual-targeting therapies like Janus kinase inhibitors may treat both alopecia areata and other immune diseases.

Memory regulatory T cells need IL-7, not IL-2, to stay in peripheral tissues.

Early intervention with JAK inhibitors may prevent alopecia areata progression.

A specific type of immune cell plays a key role in causing alopecia areata and could be a target for treatment.

Pimecrolimus boosts melanin production and movement of skin pigment cells.

Patient-derived melanocytes can potentially treat vitiligo by restoring skin pigmentation.

Special cells can help regrow hair in alopecia areata.

Targeted immune modulation can help achieve stable remission in alopecia areata.